Trial intelligence / Profile preview

M201-A in Healthy Japanese Subjects

NCT03055403Phase 1Completed

Start
Feb 2017
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial comparing M201-A Injection with Placebo (2 arms). Primary endpoint: Number of participants with adverse events. Started Feb 2017; status: completed.

02

Drugs

m201-a

Beyond the preview

Go deeper on NCT03055403.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03055403.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call